Protein kinase C inhibitors: rationale for use and potential in the treatment of bipolar disorder.
about
Review of pharmacological treatment in mood disorders and future directions for drug development.Current and emerging therapies for the management of bipolar disordersBipolar disorder: candidate drug targets.Effect of the Putative Lithium Mimetic Ebselen on Brain Myo-Inositol, Sleep, and Emotional Processing in Humans.Non-canonical wnt signals antagonize and canonical wnt signals promote cell proliferation in early kidney development.Antimanic Treatment With Tamoxifen Affects Brain Chemistry: A Double-Blind, Placebo-Controlled Proton Magnetic Resonance Spectroscopy Study.Protein Kinases C-Mediated Regulations of Drug Transporter Activity, Localization and Expression.Platelet protein kinase C and brain-derived neurotrophic factor levels in borderline personality disorder patients.Interactions of protein kinase C-α C1A and C1B domains with membranes: a combined computational and experimental study.Multiple levels of impaired neural plasticity and cellular resilience in bipolar disorder: developing treatments using an integrated translational approachPotential mechanisms of action of lithium in bipolar disorder. Current understanding.Involvement of protein kinase C and protein kinase A in the enhancement of L-type calcium current by GABAB receptor activation in neonatal hippocampus.Protein phosphorylation detection using dual-mode field-effect devices and nanoplasmonic sensors.Hippocampal protein expression is differentially affected by chronic paroxetine treatment in adolescent and adult rats: a possible mechanism of "paradoxical" antidepressant responses in young persons.Protein kinase C, an elusive therapeutic target?A role for PKC in mediating stress-induced prefrontal cortical structural plasticity and cognitive function.ENaC activity is increased in isolated, split-open cortical collecting ducts from protein kinase Cα knockout mice.Increased PKC activity and altered GSK3β/NMDAR function drive behavior cycling in HINT1-deficient mice: bipolarity or opposing forces.Probing the biology of natural products: molecular editing by diverted total synthesis.Nutrient-based therapies for bipolar disorder: a systematic review.Tamoxifen use for the management of mania: a review of current preclinical evidence.Calcium signalling and psychiatric disease: bipolar disorder and schizophrenia.Identification of a novel miRNA that increases transient protein expression in combination with valproic acid.Kinase targets in CNS drug discovery.Protein kinase C and cardiac dysfunction: a review.Protein kinase C phosphorylates the cAMP response element binding protein in the hypothalamic paraventricular nucleus during morphine withdrawal.Lithium and Tamoxifen Modulate Behavior and Protein Kinase C Activity in the Animal Model of Mania Induced by Ouabain.Role of Protein Kinase C in Bipolar Disorder: A Review of the Current Literature.Proteomic analysis of rat prefrontal cortex after chronic valproate treatment.Intracerebral Administration of BDNF Protects Rat Brain Against Oxidative Stress Induced by Ouabain in an Animal Model of Mania.Predominant recurrence polarity among 928 adult international bipolar I disorder patients.Direct and Systemic Administration of a CNS-Permeant Tamoxifen Analog Reduces Amphetamine-Induced Dopamine Release and Reinforcing Effects.Sigma 1 Receptor Antagonists Inhibit Manic-like Behaviors in Two Congenital Strains of Mice.Protein Kinase C (PKC) Isozymes and Cancer
P2860
Q26853509-425352F0-8772-42A0-A9BC-843C17B9C11CQ28686902-0BC1257E-1E41-40B6-AAC9-33FF16596AE4Q28751133-EF95E953-236A-4423-BE3D-CF04D78E17B7Q30374052-FDACCB8E-0DB1-4C33-96D6-6E8B78B8E88DQ30504866-A17804D4-6E47-4E52-8FBC-1E7F45BA5C4CQ30760720-A8571FAE-06E8-4554-9027-FDA9687949FFQ33624522-A88B1D3A-894B-4C49-93B0-83A1FA9BAD3BQ34026112-D3880BCC-0FE3-413A-AC23-93956DE3A8C3Q34074459-29981426-F833-4ECC-B6A9-D0F4BA448855Q34268501-55905C89-C317-4A53-B332-D8D63E46E333Q34325612-05855146-DBAB-45C7-89F3-8749CE4A9D86Q34687262-5F2518D2-8995-423A-9695-9A9E27FD68D0Q35570316-07C4E2D2-59E9-46AD-841E-10117CD7A45DQ36989116-97252EC7-79A4-4546-8DF0-F006C6963C36Q37141320-853C5D8D-65B9-4CF8-83D5-E5B706E44533Q37394509-43C985D8-C321-48C0-AA58-497130D53936Q37575563-6DFE5471-6A68-46A4-81E0-8B95883CCB04Q37668134-5B07A99C-188F-43EC-BD3F-D97472285BF9Q37809500-5A2AF942-9D2C-4E03-823F-6D6C1B0EAE6CQ38059360-7EBF777A-85D4-4D8A-8901-26A53E4B0971Q38179926-439B8550-6335-4C11-8C3D-D8E39DF52CDBQ38191819-39A6B0B1-7E4C-44B8-B12F-AED0BF7D47F9Q38705978-900EDC58-DE7F-4BA7-B33B-46B02A290D38Q38760031-3BA3AE55-04F6-4AA0-9FDF-186A96F9C82DQ39432092-C9042ACF-BC81-4FB9-9E0E-58FFFE98E30AQ41774031-F82AA865-5DE9-4607-AD0A-39594F1A14EDQ47109377-E6E09C40-87F3-41BD-BC68-E749F7440D99Q47303995-4EA3D5CF-98B7-45AB-B10F-F1411953F613Q48321344-71FC17DE-52F2-414E-AE54-09E1FDCFC90EQ48579986-8FA5E722-4DE9-4CF1-9531-51087E80DC79Q48779723-C48277AD-EF14-49A7-AD5C-EF7F2118790DQ51009516-3AB1F066-A9EF-4CF3-9456-B38229A0FBC9Q54977290-1012F083-1742-4CF8-97C6-252702CE2A95Q59072618-243FA373-3E9B-44A9-B376-9A1ABC7E62AE
P2860
Protein kinase C inhibitors: rationale for use and potential in the treatment of bipolar disorder.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Protein kinase C inhibitors: r ...... treatment of bipolar disorder.
@ast
Protein kinase C inhibitors: r ...... treatment of bipolar disorder.
@en
Protein kinase C inhibitors: r ...... treatment of bipolar disorder.
@nl
type
label
Protein kinase C inhibitors: r ...... treatment of bipolar disorder.
@ast
Protein kinase C inhibitors: r ...... treatment of bipolar disorder.
@en
Protein kinase C inhibitors: r ...... treatment of bipolar disorder.
@nl
prefLabel
Protein kinase C inhibitors: r ...... treatment of bipolar disorder.
@ast
Protein kinase C inhibitors: r ...... treatment of bipolar disorder.
@en
Protein kinase C inhibitors: r ...... treatment of bipolar disorder.
@nl
P2860
P1433
P1476
Protein kinase C inhibitors: r ...... treatment of bipolar disorder.
@en
P2093
Carlos A Zarate
Husseini K Manji
P2860
P304
P356
10.2165/00023210-200923070-00003
P577
2009-01-01T00:00:00Z
P6179
1017737180